Implantable optical stimulation lead and methods of making and using

Information

  • Patent Grant
  • 11511127
  • Patent Number
    11,511,127
  • Date Filed
    Tuesday, May 14, 2019
    5 years ago
  • Date Issued
    Tuesday, November 29, 2022
    a year ago
Abstract
An optical stimulation lead includes a lead body including a distal end, a distal portion, and a proximal portion; and an optical assembly attached to the distal end of the lead body. The optical assembly includes a light emitter; a feedthrough assembly including at least one ceramic block, at least one feedthrough pin extending through the at least one ceramic block and electrically coupled to the light emitter, and a metal housing attached to the at least one ceramic block; a metal tube attached to the feedthrough assembly and disposed around the light emitter; and an emitter cover disposed over the light emitter and coupled to the metal tube.
Description
FIELD

The present invention is directed to the area of implantable optical stimulation systems and methods of making and using the systems. The present invention is also directed to implantable optical stimulation leads having a light source at the distal end of the lead, as well as methods of making and using the leads and optical stimulation systems.


BACKGROUND

Implantable optical stimulation systems can provide therapeutic benefits in a variety of diseases and disorders. For example, optical stimulation can be applied to the brain either externally or using an implanted stimulation lead to provide, for example, deep brain stimulation, to treat a variety of diseases or disorders. Optical stimulation may also be combined with electrical stimulation.


Stimulators have been developed to provide therapy for a variety of treatments. A stimulator can include a control module (for generating light or electrical signals sent to light sources in a lead), one or more leads, and one or more light sources coupled to, or disposed within, each lead. The lead is positioned near the nerves, muscles, or other tissue to be stimulated.


BRIEF SUMMARY

One embodiment is an optical stimulation lead including a lead body including a distal end, a distal portion, and a proximal portion; and an optical assembly attached to the distal end of the lead body. The optical assembly includes a light emitter; a feedthrough assembly including at least one ceramic block, at least one feedthrough pin extending through the at least one ceramic block and electrically coupled to the light emitter, and a metal housing attached to the at least one ceramic block; a metal tube attached to the feedthrough assembly and disposed around the light emitter; and an emitter cover disposed over the light emitter and coupled to the metal tube.


In at least some embodiments, the optical assembly forms a hermetically sealed housing for the light emitter. In at least some embodiments, the optical assembly further includes an anchor extending proximally from the feedthrough assembly, where the anchor is configured and arranged to be inserted into the distal end of the lead body to anchor the optical assembly to the lead body. In at least some embodiments, the anchor includes a proximally tapered flange to facilitate attachment of the anchor to the lead body. In at least some embodiments, the lead body defines a lumen to receive at least a portion of the anchor to facilitate attachment of the anchor to the lead body. In at least some embodiments, the at least one ceramic block is attached to the anchor with a braze joint.


In at least some embodiments, the at least one ceramic block is attached to the metal housing with a braze joint. In at least some embodiments, the at least one ceramic block is attached to the at least one feedthrough pin with a braze joint. In at least some embodiments, the optical stimulation lead further includes at least one lead cable disposed within the optical assembly to electrically couple the at least one feedthrough pin to the light emitter.


In at least some embodiments, the at least one ceramic block is attached to the anchor to form a hermetic seal. In at least some embodiments, the at least one ceramic block is attached to the metal housing to form a hermetic seal. In at least some embodiments, the at least one ceramic block is attached to the at least one feedthrough pin to form a hermetic seal.


In at least some embodiments, the optical stimulation lead further includes terminals disposed along the proximal portion of the lead body and conductors extending along the lead body, where at least one of the conductors electrically couples the at least one feedthrough pin to at least one of the terminals of the lead. In at least some embodiments, the optical stimulation lead further includes at least one electrode disposed along the distal portion of the lead body. In at least some embodiments, at least one of the conductors electrically couples the at least one electrode to at least one of the terminals of the lead. In at least some embodiments, the lead body defines a lumens extending along the lead body, where the conductors are disposed in at least one of the lumens.


In at least some embodiments, the emitter covering is an optical diffuser. In at least some embodiments, the emitter covering is a lens.


Another embodiment is an optical stimulation system including any of the optical stimulation leads described above and a control module coupleable to the optical stimulation lead. The control module includes a housing and an electronic subassembly disposed in the housing to provide electrical signals to the light emitter of the optical stimulation lead.


In at least some embodiments, the lead further includes terminals disposed along the proximal portion of the lead body and the optical stimulation system further includes a connector for receiving the proximal portion of the lead body, the connector having a proximal end, a distal end, and a longitudinal length, the connector including a connector housing defining a port at the distal end of the connector, the port configured and arranged for receiving the proximal portion of the lead body of the optical stimulation lead, and connector contacts disposed in the connector housing, the connector contacts configured and arranged to couple to the terminals disposed along the proximal portion of the lead body of the optical stimulation lead.


In at least some embodiments, the connector is part of the control module. In at least some embodiments, the electrical stimulation system further includes a lead extension coupleable to both the electrical stimulation lead and the control module, where the connector is part of the lead extension.


Yet another embodiment is a method of stimulating patient tissue that includes implanting any of the optical stimulation leads described above into the patient tissue; and emitting light from the light emitter of the optical stimulation lead to stimulate the patient tissue.





BRIEF DESCRIPTION OF THE DRAWINGS

Non-limiting and non-exhaustive embodiments of the present invention are described with reference to the following drawings. In the drawings, like reference numerals refer to like parts throughout the various figures unless otherwise specified.


For a better understanding of the present invention, reference will be made to the following Detailed Description, which is to be read in association with the accompanying drawings, wherein:



FIG. 1 is a schematic side view of one embodiment of an optical stimulation system that includes a lead electrically coupled to a control module, according to the invention;



FIG. 2A is a schematic side view of one embodiment of the control module of FIG. 1 configured and arranged to couple to an elongated device, according to the invention;



FIG. 2B is a schematic side view of one embodiment of a lead extension configured and arranged to couple the elongated device of FIG. 2A to the control module of FIG. 1, according to the invention;



FIG. 3A is a schematic perspective view of one embodiment of a distal end of an optical stimulation lead with one embodiment of an optical assembly, according to the invention;



FIG. 3B is a schematic partially exploded view of the distal end of the optical stimulation lead of FIG. 3A, according to the invention;



FIG. 3C is a schematic exploded view of the feedthrough assembly of the optical stimulation lead of FIG. 3A, according to the invention;



FIG. 4A is a schematic exploded view of another embodiment of an optical assembly for an optical stimulation lead, according to the invention;



FIG. 4B is a schematic assembled side view of the optical assembly of FIG. 4A, according to the invention;



FIG. 4C is a schematic cross-sectional view of the optical assembly of FIG. 4A, according to the invention; and



FIG. 5 is a schematic overview of one embodiment of components of an optical stimulation system, including an electronic subassembly disposed within a control module, according to the invention.





DETAILED DESCRIPTION

The present invention is directed to the area of implantable optical stimulation systems and methods of making and using the systems. The present invention is also directed to implantable optical stimulation leads having a light source at the distal end of the lead, as well as methods of making and using the leads and optical stimulation systems.


In some embodiments, the implantable optical stimulation system only provides optical stimulation. In other embodiments, the stimulation system can include both optical and electrical stimulation. In at least some of these embodiments, the optical stimulation system can be a modification of an electrical stimulation system to also provide optical stimulation. Suitable implantable electrical stimulation systems that can be modified to also provide optical stimulation include, but are not limited to, a least one lead with one or more electrodes disposed along a distal end of the lead and one or more terminals disposed along the one or more proximal ends of the lead. Leads include, for example, percutaneous leads, paddle leads, and cuff leads. Examples of electrical stimulation systems with leads are found in, for example, U.S. Pat. Nos. 6,181,969; 6,516,227; 6,609,029; 6,609,032; 6,741,892; 7,244,150; 7,450,997; 7,672,734; 7,761,165; 7,783,359; 7,792,590; 7,809,446; 7,949,395; 7,974,706; 6,175,710; 6,224,450; 6,271,094; 6,295,944; 6,364,278; and 6,391,985; U.S. Patent Applications Publication Nos. 2007/0150036; 2009/0187222; 2009/0276021; 2010/0076535; 2010/0268298; 2011/0004267; 2011/0078900; 2011/0130817; 2011/0130818; 2011/0238129; 2011/0313500; 2012/0016378; 2012/0046710; 2012/0071949; 2012/0165911; 2012/0197375; 2012/0203316; 2012/0203320; 2012/0203321; 2012/0316615; and 2013/0105071; and U.S. patent application Ser. Nos. 12/177,823 and 13/750,725, all of which are incorporated by reference in their entireties.



FIG. 1 illustrates schematically one embodiment of an optical stimulation system 100. The optical stimulation system includes a control module (e.g., a stimulator) 102 and a lead 103 coupleable to the control module 102. The lead 103 includes one or more lead bodies 106. In FIG. 1, the lead 103 is shown having a single lead body 106. In FIG. 2B, the lead 103 includes two lead bodies. It will be understood that the lead 103 can include any suitable number of lead bodies including, for example, one, two, three, four, five, six, seven, eight or more lead bodies 106.


At least one light emitter 135 is provided at a distal end of the lead 103. The light emitter 135 can be a light source, such as a light emitting diode (LED), laser diode, organic light emitting diode (OLED), or the like. Optionally, the lead can also include one or more electrodes 134 disposed along the lead body 106, and one or more terminals (e.g., 310 in FIG. 2A-2B) disposed along each of the one or more lead bodies 106 and coupled to the optional electrodes 134 by conductors (not shown). In at least some embodiments, one or more terminals (e.g., 310 in FIG. 2A-2B) may also be used to convey electrical signals to a light source that acts as the light emitter 135 by conductors (not shown) extending along the lead.


The lead 103 can be coupled to the control module 102 in any suitable manner. In some embodiments, the lead is permanently attached to the control module 102. In other embodiments, the lead can be coupled to the control module 102 by a connector (e.g., connector 144 of FIG. 2A). In FIG. 2A, the lead 103 is shown coupling directly to the control module 102 through the connector 144. In at least some other embodiments, the lead 103 couples to the control module 102 via one or more intermediate devices, as illustrated in FIG. 2B. For example, in at least some embodiments one or more lead extensions 324 (see e.g., FIG. 2B) can be disposed between the lead 103 and the control module 102 to extend the distance between the lead 103 and the control module 102. Other intermediate devices may be used in addition to, or in lieu of, one or more lead extensions including, for example, a splitter, an adaptor, or the like or combinations thereof. It will be understood that, in the case where the stimulation system 100 includes multiple elongated devices disposed between the lead 103 and the control module 102, the intermediate devices may be configured into any suitable arrangement.


The control module 102 can include, for example, a connector housing 112 and a sealed electronics housing 114. An electronic subassembly 110 and an optional power source 120 are disposed in the electronics housing 114. A control module connector 144 is disposed in the connector housing 112. The control module connector 144 is configured and arranged to make an electrical connection between the lead 103 and the electronic subassembly 110 of the control module 102.


The stimulation system or components of the stimulation system, including the lead 103 and the control module 102, are typically implanted into the body of a patient. The stimulation system can be used for a variety of applications including, but not limited to brain stimulation, deep brain stimulation, neural stimulation, spinal cord stimulation, muscle stimulation, and the like.


If the lead includes the optional electrodes 134, the electrodes can be formed using any conductive, biocompatible material. Examples of suitable materials include metals, alloys, conductive polymers, conductive carbon, and the like, as well as combinations thereof. In at least some embodiments, one or more of the electrodes 134 are formed from one or more of: platinum, platinum iridium, palladium, palladium rhodium, or titanium. Any suitable number of electrodes 134 can be disposed on the lead including, for example, one, two, three, four, five, six, seven, eight, nine, ten, eleven, twelve, fourteen, sixteen, twenty-four, thirty-two, or more electrodes 134.


The one or more lead bodies 106 are made of a non-conductive, biocompatible material such as, for example, silicone, polyurethane, polyetheretherketone (“PEEK”), epoxy, and the like or combinations thereof. The one or more lead bodies 106 may be formed in the desired shape by any process including, for example, molding (including injection molding), casting, and the like.


One or more terminals (e.g., 310 in FIGS. 2A-2B) are typically disposed along the proximal end of the one or more lead bodies 106 of the stimulation system 100 (as well as any splitters, lead extensions, adaptors, or the like) for electrical connection to corresponding connector contacts (e.g., 314 in FIGS. 2A-2B). The connector contacts are disposed in connectors (e.g., 144 in FIGS. 1-2B; and 322FIG. 2B) which, in turn, are disposed on, for example, the control module 102 (or a lead extension, a splitter, an adaptor, or the like). Electrically conductive wires, cables, or the like (not shown) extend from the terminals to the light emitter 135 or optional one or more electrodes 134.


The electrically conductive wires (“conductors”) may be embedded in the non-conductive material of the lead body 106 or can be disposed in one or more lumens (not shown) extending along the lead body 106. In some embodiments, there is an individual lumen for each conductor. In other embodiments, two or more conductors extend through a lumen. There may also be one or more lumens (not shown) that open at, or near, the proximal end of the one or more lead bodies 106, for example, for inserting a stylet to facilitate placement of the one or more lead bodies 106 within a body of a patient. Additionally, there may be one or more lumens (not shown) that open at, or near, the distal end of the one or more lead bodies 106, for example, for infusion of drugs or medication into the site of implantation of the one or more lead bodies 106. In at least one embodiment, the one or more lumens are flushed continually, or on a regular basis, with saline, epidural fluid, or the like. In at least some embodiments, the one or more lumens are permanently or removably sealable at the distal end.



FIG. 2A is a schematic side view of one embodiment of a proximal end of one or more elongated devices 300 configured and arranged for coupling to one embodiment of the control module connector 144. The one or more elongated devices may include, for example, one or more of the lead bodies 106 of FIG. 1, one or more intermediate devices (e.g., a splitter, the lead extension 324 of FIG. 2B, an adaptor, or the like or combinations thereof), or a combination thereof.


The control module connector 144 defines at least one port into which a proximal end of the elongated device 300 can be inserted, as shown by directional arrows 312a and 312b. In FIG. 2A (and in other figures), the connector housing 112 is shown having two ports 304a and 304b. The connector housing 112 can define any suitable number of ports including, for example, one, two, three, four, five, six, seven, eight, or more ports.


The control module connector 144 also includes a plurality of connector contacts, such as connector contact 314, disposed within each port 304a and 304b. When the elongated device 300 is inserted into the ports 304a and 304b, the connector contacts 314 can be aligned with a plurality of terminals 310 disposed along the proximal end(s) of the elongated device(s) 300 to electrically couple the control module 102 to the electrodes (134 of FIG. 1) disposed on the paddle body 104 of the lead 103. Each of the terminals 310 can couple to the light emitter 135 or one or more of the optional electrodes 134. Examples of connectors in control modules are found in, for example, U.S. Pat. Nos. 7,244,150 and 8,224,450, which are incorporated by reference.



FIG. 2B is a schematic side view of another embodiment of the stimulation system 100. The stimulation system 100 includes a lead extension 324 that is configured and arranged to couple one or more elongated devices 300 (e.g., one of the lead bodies 106 of FIG. 1, a splitter, an adaptor, another lead extension, or the like or combinations thereof) to the control module 102. In FIG. 2B, the lead extension 324 is shown coupled to a single port 304 defined in the control module connector 144. Additionally, the lead extension 324 is shown configured and arranged to couple to a single elongated device 300. In alternate embodiments, the lead extension 324 is configured and arranged to couple to multiple ports 304 defined in the control module connector 144 (e.g., the ports 304a and 304b of FIG. 1), or to receive multiple elongated devices 300 (e.g., both of the lead bodies 106 of FIG. 1), or both.


A lead extension connector 322 is disposed on the lead extension 324. In FIG. 2B, the lead extension connector 322 is shown disposed at a distal end 326 of the lead extension 324. The lead extension connector 322 includes a connector housing 328. The connector housing 328 defines at least one port 330 into which terminals 310 of the elongated device 300 can be inserted, as shown by directional arrow 338. Each of the terminals 310 can couple to the light emitter 135 or one or more of the optional electrodes 134. The connector housing 328 also includes a plurality of connector contacts, such as connector contact 340. When the elongated device 300 is inserted into the port 330, the connector contacts 340 disposed in the connector housing 328 can be aligned with the terminals 310 of the elongated device 300 to electrically couple the lead extension 324 to the electrodes (134 of FIG. 1) disposed along the lead (103 in FIG. 1).


In at least some embodiments, the proximal end of the lead extension 324 is similarly configured and arranged as a proximal end of the lead 103 (or other elongated device 300). The lead extension 324 may include a plurality of electrically conductive wires (not shown) that electrically couple the connector contacts 340 to a proximal end 348 of the lead extension 324 that is opposite to the distal end 326. In at least some embodiments, the conductive wires disposed in the lead extension 324 can be electrically coupled to a plurality of terminals (not shown) disposed along the proximal end 348 of the lead extension 324. In at least some embodiments, the proximal end 348 of the lead extension 324 is configured and arranged for insertion into a connector disposed in another lead extension (or another intermediate device). In other embodiments (and as shown in FIG. 2B), the proximal end 348 of the lead extension 324 is configured and arranged for insertion into the control module connector 144.



FIG. 3A illustrates the distal end of one embodiment of a lead 403 with a lead body 406, an optical assembly 460 containing a light emitter 435 attached to the distal end of the lead body, and two optional electrodes 434 disposed along the lead body. FIG. 3B is an exploded view of the components of the optical assembly 460. In at least some embodiments, the optical assembly 460 provides a hermetically sealed housing for the light emitter 435.


In the illustrated embodiment of FIGS. 3A and 3B, the optical assembly 460 includes the light emitter 435, an emitter cover 462, a feedthrough assembly 464, feedthrough pins 466, conductive cables 468, a metal tube 470, and an anchor 472. The light emitter 435 emits light in response to electrical signals transmitted along the lead 403. Any suitable light emitter can be used including, but not limited to, a light emitting diode (LED), laser diode, organic light emitting diode (OLED), or the like. The light emitter 435 can emit one or more wavelengths of light or can emit light in one or more wavelength bands. The wavelength or wavelength band can be visible, infrared, or ultraviolet light. In at least some embodiments, the light emitter 435 emits visible light. In at least some embodiments, the light emitter 435 emits light at one or more wavelengths in a range of 500 to 800 nm or in a range of 600 to 700 nm. Although FIGS. 3A and 3B illustrate a single light emitter 435, it will be understood that other embodiments can include multiple light emitters. Those light emitters may emit light at a same wavelength or wavelength band or some, or all, of the light emitters may emit light at different wavelengths or wavelength bands.


In at least some embodiments, the light emitter 435 includes an emitter element 480, a flange 482 or other housing, and at least two contacts 484. The emitter element 480 may also include a protective material (such as a ceramic or polymeric material) disposed around the actual light emitting structure. The flange 482 can be made of any suitable material and may provide structural or positional stability for the emitter element 480 within the optical assembly 460. The contacts 484 can be pins, pads, or any other structure that provides for electrical coupling of the emitter element 480 to other components, such as the conductive cables 468 or feedthrough pins 466. The conductive cables 468 of the optical assembly 460 can be conductive wires, pins, or any other suitable conductive structure to electrically couple the contacts 484 of the light emitter 435 to the feedthrough pins 466. It will be understood that in other embodiments, the contacts 484 can be coupled directly to the feedthrough pins 466 without the use of conductive cables.


In at least some embodiments, an emitter cover 462 is disposed over the light emitter 435. In at least some embodiments, the emitter cover 462 can be an optical component such as an optical diffuser or lens. For example, a sapphire optical diffuser dome can be positioned over the light emitter. In other embodiments, the emitter cover 462 may be an optically transparent or translucent material to seal the light emitter 435 within the optical assembly 460. In some embodiments, the emitter cover 462 can be part of a package that forms the light emitter 435.



FIG. 3C illustrates an exploded view of one embodiment of the feedthrough assembly 464 which includes a ceramic block 474 through which the feedthrough pins 466 pass and a metal housing 476 surrounding a portion of the ceramic block. In at least some embodiments, the ceramic block 474 and metal housing 476 are physically attached together by a braze joint 490. For example, the metal housing 476 can be made of titanium and the braze joint 490 can be a gold (or gold alloy) braze joint. In other embodiments, other methods of attachment can be use such as, for example, an adhesive, or the ceramic block 474 and metal housing 476 may be coupled together by a frictional, interference, or compression fit or any combination thereof.


The feedthrough pins 466 are also made of metal. In at least some embodiments, the ceramic block 474 and feedthrough pins 466 are physically attached together by a braze joint 492. For example, the feedthrough pins 466 can be made of platinum, iridium, platinum/iridium alloy, or any other suitable material and the braze joint 490 can be a gold (or gold alloy) braze joint. In other embodiments, other methods of attachment can be use such as, for example, an adhesive, or the ceramic block 474 and feedthrough pins 466 may be coupled together by a frictional, interference, or compression fit or any combination thereof.


The anchor 472 is coupled to, and extends away from, the feedthrough assembly 464. The anchor 472 can be made of metal or any other suitable material and is shaped to fit into a lumen 480 in the lead body 406. The anchor 472 can be physical attached to the ceramic block 474 (or, in other embodiments, the metal housing 476) by a braze joint 494 (for example, a gold or gold alloy braze for a titanium anchor) or using adhesive or any other suitable attachment method or the ceramic block 474 and anchor 472 can be coupled by a frictional, interference, or compression fit, or any combination thereof. In at least some embodiments, the anchor 472 forms a frictional or compression fit with the lumen 480 of the lead body. In at least some embodiments, the polymeric material of the lead body 406 may be heated to allow the material to reflow around the anchor 472 to enhance the attachment of the anchor to the lead body. In at least some embodiments, the anchor 472 can include a flange 473 at the proximal end of the anchor to engage the lead body 406. In the illustrated body, the flange 473 tapers in a proximal direction to facilitate inserting the anchor 472 into the lumen 480 of the lead body 406.


Turning back to FIGS. 3A and 3B, a metal tube 470 is disposed around the light emitter 435 and coupled to the metal housing 476 of the feedthrough assembly 464. The metal housing 476 can be attached to the metal tube 470 by welding or any other suitable attachment method including, but not limited to, adhesive or a frictional, interference, or compression fit, or any combination thereof. The metal tube 470 can be attached to the optical diffuser or lens 462 by brazing, adhesive, or a frictional, interference, or compression fit, or any combination thereof.


In at least some embodiments, the optical assembly 460 provides a hermetically sealed housing for the light emitter 435 which prevents or resists the flow of fluids into the optical assembly 460. For example, the use of welding and brazing to couple the components of the optical assembly 460, as described above, may facilitate or provide the hermetical sealing of the optical assembly 460.


The lead body 406 of the illustrated embodiment includes a central lumen 480 and multiple peripheral lumens 481. As indicated above, the anchor 472 can be inserted into the distal portion of the central lumen 480. The central lumen may also be used for insertion of a stylet during implantation, as discussed above.


One or more of the peripheral lumens 481 can carry conductors (not shown), such as conductive wires or cables. In at least some embodiments, the feedthrough pins 466 can be inserted into one or more of the peripheral lumens 481 and can be coupled to the conductors carried in those lumens in order to transmit electrical signals from the control module through the conductors to the optical assembly 460. In at least some embodiments, conductors in one or more of the peripheral lumens 481 can also be coupled to the optional electrodes 434, as described above and in the references cited above.



FIGS. 4A-4C illustrate another embodiment of an optical assembly 560 for a lead 403 (FIG. 3A). The optical assembly includes a light emitter 535, an emitter cover 562, a feedthrough assembly 564, one or more feedthrough pins 566, a connector plate 567, an insulator disc 569, a metal tube 570, a distal seal 571, and an anchor 572. The light emitter 535 emits light in response to electrical signals transmitted along the lead 403. The anchor 572 is similar to anchor 472 described above and can be attached to the lead 403 using any of the same methods and arrangements described above.



FIG. 4A is an exploded view and FIG. 4B is an assembled view of the optical assembly 560. FIG. 4C is a cross-sectional view of the optical assembly 560 and further illustrates that the feedthrough assembly 564 includes two ceramic blocks 574 (although in other embodiments, a single ceramic block forming an annulus around the anchor 572 can be used) through which the feedthrough pins 566 pass and a metal housing 576 surrounding the ceramic blocks. A joint 577 (FIGS. 4B and 4C) (for example, a weld joint) is formed between the metal tube 570 and metal housing 576. In at least some embodiments, the ceramic blocks 574 and metal housing 576 are physically or chemically attached together to form a seal or, preferably, a hermetic seal. For example, the metal housing 576 can be made of titanium or other metal and the ceramic blocks 574 can be made of Kryoflex™ (available from PA&E, Wenatchee, Wash.) or other ceramic material that can form a hermetic seal with the metal housing when both are fired or otherwise chemically activated. In other embodiments, the metal housing 576 and ceramic blocks 574 can be joined to form a seal (or, in some embodiments, a hermetic seal) by brazing or other joining techniques such as, for example, an adhesive, or the ceramic blocks 574 and metal housing 576 may be coupled together by a frictional, interference, or compression fit or any combination thereof.


The feedthrough pins 466 and the anchor 462 are made of metal and can be joined to the ceramic blocks 574 using the same methods of joining as described above for joining the metal housing 576 and ceramic blocks 574. Similarly, the proximal seal 572 can be made of a ceramic material, such as Kryoflex™, and can be joined to the metal tube 570 (which is made of titanium or other metal) using the same methods of joining as described above for joining the metal housing 576 and ceramic blocks 574. The metal tube 570 and metal housing 576 are then joined by welding or other suitable joining techniques.


Any suitable light emitter 535 can be used including, but not limited to, the light emitters described above for use as light emitter 435. In at least some embodiments, the light emitter 535 includes an emitter element, a housing, and at least two contacts, as describe above for light emitter 535. The contacts of the light emitter can be pins, pads, or any other structure. One contact is coupled to one of the feedback pins 566 (directly or through a conductor 568 illustrated in FIG. 4A) and the other contact is coupled to the other feedback pin 566 using the conductor plate 567 (for example, a nickel conductor plate) and, optionally, a conductive adhesive, conductive wire, or the like. An insulator disc 569 (for example, a disc made of Kapton™) is provided under conductor plate 567 to provide insulation between the two feedback pins 566 and the metal housing 576 of the feedback assembly 564.


In at least some embodiments, an emitter cover 562 is disposed over the light emitter 535. In at least some embodiments, the emitter cover 562 can be an optical component such as an optical diffuser or lens. For example, a sapphire optical diffuser dome can be positioned over the light emitter. In other embodiments, the emitter cover 562 may be an optically transparent or translucent material to seal the light emitter 535 within the optical assembly 560. In some embodiments, the emitter cover 562 can be part of a package that forms the light emitter 535.


In at least some embodiments, the optical assembly 560 provides a hermetically sealed housing for the light emitter 535 which prevents or resists the flow of fluids into the optical assembly 560. For example, the use of welding, brazing, or Kryoflex™ or combinations thereof to couple the components of the optical assembly 560, as described above, may facilitate or provide the hermetical sealing of the optical assembly 560.



FIG. 5 is a schematic overview of one embodiment of components of an optical stimulation system 500 including an electronic subassembly 610 disposed within a control module. It will be understood that the optical stimulation system can include more, fewer, or different components and can have a variety of different configurations including those configurations disclosed in the stimulator references cited herein.


Some of the components (for example, a power source 612, an antenna 618, a receiver 602, and a processor 604) of the optical stimulation system can be positioned on one or more circuit boards or similar carriers within a sealed housing of an implantable pulse generator, if desired. Any power source 612 can be used including, for example, a battery such as a primary battery or a rechargeable battery. Examples of other power sources include super capacitors, nuclear or atomic batteries, mechanical resonators, infrared collectors, thermally-powered energy sources, flexural powered energy sources, bioenergy power sources, fuel cells, bioelectric cells, osmotic pressure pumps, and the like including the power sources described in U.S. Pat. No. 7,437,193, incorporated herein by reference.


As another alternative, power can be supplied by an external power source through inductive coupling via the optional antenna 618 or a secondary antenna. The external power source can be in a device that is mounted on the skin of the user or in a unit that is provided near the user on a permanent or periodic basis.


If the power source 612 is a rechargeable battery, the battery may be recharged using the optional antenna 618, if desired. Power can be provided to the battery for recharging by inductively coupling the battery through the antenna to a recharging unit 616 external to the user. Examples of such arrangements can be found in the references identified above.


In one embodiment, light is emitted by the light emitter 135 of the lead body to stimulate nerve fibers, muscle fibers, or other body tissues near the optical stimulation system. The processor 604 is generally included to control the timing and other characteristics of the optical stimulation system. For example, the processor 604 can, if desired, control one or more of the timing, pulse frequency, strength, duration, and waveform of the optical stimulation. In addition, the processor 604 can select one or more of the optional electrodes to provide electrical stimulation, if desired. In some embodiments, the processor 604 selects which of the optional electrode(s) are cathodes and which electrode(s) are anodes.


Any processor can be used and can be as simple as an electronic device that, for example, produces optical stimulation at a regular interval or the processor can be capable of receiving and interpreting instructions from an external programming unit 608 that, for example, allows modification of stimulation characteristics. In the illustrated embodiment, the processor 604 is coupled to a receiver 602 which, in turn, is coupled to the optional antenna 618. This allows the processor 604 to receive instructions from an external source to, for example, direct the stimulation characteristics and the selection of electrodes, if desired.


In one embodiment, the antenna 618 is capable of receiving signals (e.g., RF signals) from an external telemetry unit 606 which is programmed by the programming unit 608. The programming unit 608 can be external to, or part of, the telemetry unit 606. The telemetry unit 606 can be a device that is worn on the skin of the user or can be carried by the user and can have a form similar to a pager, cellular phone, or remote control, if desired. As another alternative, the telemetry unit 606 may not be worn or carried by the user but may only be available at a home station or at a clinician's office. The programming unit 608 can be any unit that can provide information to the telemetry unit 606 for transmission to the optical stimulation system 600. The programming unit 608 can be part of the telemetry unit 606 or can provide signals or information to the telemetry unit 606 via a wireless or wired connection. One example of a suitable programming unit is a computer operated by the user or clinician to send signals to the telemetry unit 606.


The signals sent to the processor 604 via the antenna 618 and the receiver 602 can be used to modify or otherwise direct the operation of the optical stimulation system. For example, the signals may be used to modify the stimulation characteristics of the optical stimulation system such as modifying one or more of stimulation duration, pulse frequency, waveform, and stimulation amplitude. The signals may also direct the optical stimulation system 600 to cease operation, to start operation, to start charging the battery, or to stop charging the battery. In other embodiments, the stimulation system does not include the antenna 618 or receiver 602 and the processor 604 operates as programmed.


Optionally, the optical stimulation system 600 may include a transmitter (not shown) coupled to the processor 604 and the antenna 618 for transmitting signals back to the telemetry unit 606 or another unit capable of receiving the signals. For example, the optical stimulation system 600 may transmit signals indicating whether the optical stimulation system 600 is operating properly or not or indicating when the battery needs to be charged or the level of charge remaining in the battery. The processor 604 may also be capable of transmitting information about the stimulation characteristics so that a user or clinician can determine or verify the characteristics.


The above specification provides a description of the structure, manufacture, and use of the invention. Since many embodiments of the invention can be made without departing from the spirit and scope of the invention, the invention also resides in the claims hereinafter appended.

Claims
  • 1. An optical stimulation lead, comprising: a lead body comprising a distal end, a distal portion, and a proximal portion; andan optical assembly attached to the distal end of the lead body and comprising a light emitter,a hermetically sealed housing disposed around the light emitter and comprising an emitter cover disposed over the light emitter,a plurality of feedthrough pins extending out of the hermetically sealed housing, wherein each of the feedthrough pins is electrically coupled to the light emitter, anda plurality of conductive cables disposed within the optical assembly to electrically couple the feedthrough pins to the light emitter.
  • 2. The optical stimulation lead of claim 1, wherein the hermetically sealed housing further comprises at least one ceramic block, wherein each of the feedthrough pins extends through the at least one ceramic block.
  • 3. The optical stimulation lead of claim 2, wherein the hermetically sealed housing further comprises a metal housing coupled to the at least one ceramic block.
  • 4. The optical stimulation lead of claim 3, wherein the hermetically sealed housing further comprises a metal tube coupled to the metal housing and the emitter cover.
  • 5. The optical stimulation lead of claim 1, wherein the light emitter comprises an emitter element and a flange disposed around the emitter element to provide structural or positional stability for the emitter element within the hermetically sealed housing.
  • 6. The optical stimulation lead of claim 1, wherein the optical assembly further comprises an anchor extending proximally from the hermetically sealed housing, wherein the anchor is configured and arranged to be inserted into the distal end of the lead body to anchor the optical assembly to the lead body.
  • 7. The optical stimulation lead of claim 6, wherein the anchor comprises a proximally tapered flange to facilitate attachment of the anchor to the lead body.
  • 8. The optical stimulation lead of claim 7, wherein the lead body defines a lumen that is configured and arranged to receive at least a portion of the anchor to facilitate attachment of the anchor to the lead body.
  • 9. The optical stimulation lead of claim 6, wherein the hermetically sealed housing further comprises at least one ceramic block, wherein the at least one ceramic block is attached to the anchor.
  • 10. The optical stimulation lead of claim 1, further comprising a plurality of terminals disposed along the proximal portion of the lead body, wherein each of the feedthrough pins is electrically coupled to a different one of the terminals.
  • 11. The optical stimulation lead of claim 1, wherein the lead body defines a plurality of lumens extending along the lead body, wherein the conductors extend along at least one of the lumens.
  • 12. The optical stimulation lead of claim 1, wherein the emitter cover comprises an optical diffuser.
  • 13. An optical stimulation system, comprising: the optical stimulation lead of claim 1; anda control module coupleable to the optical stimulation lead, the control module comprising a housing, and an electronic subassembly disposed in the housing and configured and arranged to provide electrical signals to the light emitter of the optical stimulation lead.
  • 14. The optical stimulation system of claim 13, wherein the optical stimulation lead further comprises a plurality of terminals disposed along the proximal portion of the lead body, the optical stimulation system further comprising a connector for receiving the proximal portion of the lead body, the connector having a proximal end, a distal end, and a longitudinal length, the connector comprising a connector housing defining a port at the distal end of the connector, the port configured and arranged for receiving the proximal portion of the lead body of the optical stimulation lead, anda plurality of connector contacts disposed in the connector housing, the plurality of connector contacts configured and arranged to couple to the plurality of terminals disposed along the proximal portion of the lead body of the optical stimulation lead.
  • 15. The optical stimulation system of claim 14, wherein the connector is part of the control module.
  • 16. The optical stimulation system of claim 14, further comprising a lead extension coupleable to both the optical stimulation lead and the control module, wherein the connector is part of the lead extension.
  • 17. A method of stimulating patient tissue, the method comprising: implanting the optical stimulation lead of claim 1 into the patient tissue; andemitting light from the light emitter of the optical stimulation lead to stimulate the patient tissue.
  • 18. An optical stimulation lead, comprising: a lead body comprising a distal end, a distal portion, and a proximal portion;at least one electrode disposed along the distal portion of the lead body; andan optical assembly attached to the distal end of the lead body and comprising a light emitter, a hermetically sealed housing disposed around the light emitter and comprising an emitter cover disposed over the light emitter, anda plurality of feedthrough pins extending out of the hermetically sealed housing, wherein each of the feedthrough pins is electrically coupled to the light emitter.
  • 19. The optical stimulation lead of claim 18, further comprising a plurality of conductive cables disposed within the optical assembly to electrically couple the feedthrough pins to the light emitter.
  • 20. An optical stimulation lead, comprising: a lead body comprising a distal end, a distal portion, and a proximal portion; andan optical assembly attached to the distal end of the lead body and comprising a light emitter,a hermetically sealed housing disposed around the light emitter and comprising an emitter cover disposed over the light emitter, wherein the emitter cover comprises a lens, anda plurality of feedthrough pins extending out of the hermetically sealed housing, wherein each of the feedthrough pins is electrically coupled to the light emitter.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. patent application Ser. No. 15/421,001, filed Jan. 31, 2017, which claims priority to U.S. Provisional Patent Application Ser. No. 62/292,083, filed Feb. 5, 2016, and U.S. Provisional Patent Application Ser. No. 62/424,130, filed Nov. 18, 2016, all of which are incorporated herein by reference in their entirety.

US Referenced Citations (260)
Number Name Date Kind
4920979 Bullara May 1990 A
5076270 Stutz, Jr. Dec 1991 A
5437193 Schleitweiler et al. Aug 1995 A
5445608 Chen Aug 1995 A
5556421 Prutchi et al. Sep 1996 A
5824027 Hoffer et al. Oct 1998 A
6175710 Kamaji et al. Jan 2001 B1
6181969 Gord Jan 2001 B1
6224450 Norton May 2001 B1
6271094 Boyd et al. Aug 2001 B1
6295944 Lovett Oct 2001 B1
6364278 Lin et al. Apr 2002 B1
6366719 Heath et al. Apr 2002 B1
6391985 Goode et al. May 2002 B1
6442435 King et al. Aug 2002 B2
6516227 Meadows et al. Feb 2003 B1
6609029 Mann et al. Aug 2003 B1
6609032 Woods et al. Aug 2003 B1
6741892 Meadows et al. May 2004 B1
6895280 Meadows et al. May 2005 B2
6988001 Greatbatch Jan 2006 B2
6993384 Bradley et al. Jan 2006 B2
7190993 Sharma et al. Mar 2007 B2
7244150 Brase et al. Jul 2007 B1
7252677 Burwell et al. Aug 2007 B2
7288108 DiMauro et al. Oct 2007 B2
7395118 Erickson Jul 2008 B2
7437193 Parramon et al. Oct 2008 B2
7450997 Pianca et al. Nov 2008 B1
7672734 Anderson et al. Mar 2010 B2
7684869 Bradley et al. Mar 2010 B2
7736382 Webb et al. Jun 2010 B2
7761165 He et al. Jul 2010 B1
7783359 Meadows Aug 2010 B2
7792590 Pianca et al. Sep 2010 B1
7803021 Brase Sep 2010 B1
7809446 Meadows Oct 2010 B2
7946980 Reddy et al. May 2011 B2
7949395 Kuzma May 2011 B2
7949409 Bly et al. May 2011 B2
7974706 Moffitt et al. Jul 2011 B2
8086322 Schouenborg Dec 2011 B2
8175710 He May 2012 B2
8224450 Brase Jul 2012 B2
8271094 Moffitt et al. Sep 2012 B1
8295944 Howard et al. Oct 2012 B2
8311647 Bly Nov 2012 B2
8326433 Blum et al. Dec 2012 B2
8340785 Bonde et al. Dec 2012 B2
8364278 Pianca et al. Jan 2013 B2
8386054 North Feb 2013 B2
8391985 McDonald Mar 2013 B2
8463343 Kuhn et al. Jun 2013 B2
8473061 Moffitt et al. Jun 2013 B2
8483237 Zimmermann et al. Jul 2013 B2
8525027 Lindner et al. Sep 2013 B2
8571665 Moffitt et al. Oct 2013 B2
8600509 McDonald et al. Dec 2013 B2
8675945 Barnhorst et al. Mar 2014 B2
8682439 DeRohan et al. Mar 2014 B2
8688235 Pianca et al. Apr 2014 B1
8792993 Pianca et al. Jul 2014 B2
8831731 Blum et al. Sep 2014 B2
8831742 Pianca et al. Sep 2014 B2
8831746 Swanson Sep 2014 B2
8849632 Sparks et al. Sep 2014 B2
8868211 Durand et al. Oct 2014 B2
8897876 Sundaramurthy et al. Nov 2014 B2
8929973 Webb et al. Jan 2015 B1
8936630 Denison et al. Jan 2015 B2
8958615 Blum et al. Feb 2015 B2
9238132 Barker Jan 2016 B2
9409032 Brase et al. Aug 2016 B2
9415154 Leven Aug 2016 B2
9421362 Seeley Aug 2016 B2
9440066 Black Sep 2016 B2
9550063 Wolf, II Jan 2017 B2
9604068 Malinowski Mar 2017 B2
9643010 Ranu May 2017 B2
9656093 Villarta et al. May 2017 B2
9681809 Sharma et al. Jun 2017 B2
9770598 Malinowski et al. Sep 2017 B2
9931511 Kaula et al. Apr 2018 B2
10307602 Leven Jun 2019 B2
10471273 Segev et al. Nov 2019 B2
11395923 Lu Jul 2022 B2
20020156513 Borkan Oct 2002 A1
20020161417 Scribner Oct 2002 A1
20040098063 Goetz May 2004 A1
20040147964 Nolan et al. Jul 2004 A1
20050096720 Sharma et al. May 2005 A1
20050216072 Mahadevan-Jansen et al. Sep 2005 A1
20060129210 Cantin et al. Jun 2006 A1
20060155348 deCharms Jul 2006 A1
20060161227 Walsh, Jr. et al. Jul 2006 A1
20070053996 Boyden et al. Mar 2007 A1
20070100398 Sloan May 2007 A1
20070150036 Anderson Jun 2007 A1
20070161919 DiLorenzo Jul 2007 A1
20070244526 Zaghetto et al. Oct 2007 A1
20080046053 Wagner et al. Feb 2008 A1
20080077198 Webb et al. Mar 2008 A1
20080146890 LeBoeuf et al. Jun 2008 A1
20080167701 John et al. Jul 2008 A1
20080197300 Kayser et al. Aug 2008 A1
20080243218 Bottomley et al. Oct 2008 A1
20090054954 Foley Feb 2009 A1
20090054955 Kopell et al. Feb 2009 A1
20090069871 Mahadevan-Jansen et al. Mar 2009 A1
20090118800 Deisseroth et al. May 2009 A1
20090187222 Barker Jul 2009 A1
20090196471 Goetz et al. Aug 2009 A1
20090276021 Meadows et al. Nov 2009 A1
20090287272 Kokones et al. Nov 2009 A1
20090287273 Carlton et al. Nov 2009 A1
20090299447 Jensen et al. Dec 2009 A1
20100076508 McDonald et al. Mar 2010 A1
20100076535 Pianca et al. Mar 2010 A1
20100094364 McDonald Apr 2010 A1
20100105997 Ecker et al. Apr 2010 A1
20100114190 Bendett et al. May 2010 A1
20100174329 Dadd et al. Jul 2010 A1
20100174344 Dadd et al. Jul 2010 A1
20100256693 McDonald et al. Oct 2010 A1
20100268298 Moffitt et al. Oct 2010 A1
20100292758 Lee et al. Nov 2010 A1
20100292759 Hahn et al. Nov 2010 A1
20100324630 Lee et al. Dec 2010 A1
20100326701 McDonald Dec 2010 A1
20110004267 Meadows Jan 2011 A1
20110005069 Pianca Jan 2011 A1
20110009932 McDonald et al. Jan 2011 A1
20110022100 Brase et al. Jan 2011 A1
20110029055 Tidemand Feb 2011 A1
20110046432 Simon et al. Feb 2011 A1
20110046700 McDonald et al. Feb 2011 A1
20110078900 Pianca et al. Apr 2011 A1
20110106208 Faltys et al. May 2011 A1
20110112591 Seymour et al. May 2011 A1
20110125077 Denison et al. May 2011 A1
20110125078 Denison May 2011 A1
20110130803 McDonald Jun 2011 A1
20110130816 Howard et al. Jun 2011 A1
20110130817 Chen Jun 2011 A1
20110130818 Chen Jun 2011 A1
20110172653 Schneider et al. Jul 2011 A1
20110172725 Wells et al. Jul 2011 A1
20110238129 Moffitt et al. Sep 2011 A1
20110295331 Wells et al. Dec 2011 A1
20110313500 Barker et al. Dec 2011 A1
20120014580 Blum et al. Jan 2012 A1
20120016378 Pianca et al. Jan 2012 A1
20120046710 Digiore et al. Feb 2012 A1
20120046715 Moffitt et al. Feb 2012 A1
20120071949 Pianca et al. Mar 2012 A1
20120165911 Pianca Jun 2012 A1
20120197375 Pianca et al. Aug 2012 A1
20120203316 Moffitt et al. Aug 2012 A1
20120203320 Digiore et al. Aug 2012 A1
20120203321 Moffitt et al. Aug 2012 A1
20120232354 Ecker et al. Sep 2012 A1
20120253261 Poletto et al. Oct 2012 A1
20120265262 Osorio Oct 2012 A1
20120265268 Blum et al. Oct 2012 A1
20120287420 McLaughlin et al. Nov 2012 A1
20120314924 Carlton et al. Dec 2012 A1
20120316615 Digiore et al. Dec 2012 A1
20130019325 Deisseroth et al. Jan 2013 A1
20130053905 Wagner Feb 2013 A1
20130079848 Campbell et al. Mar 2013 A1
20130102861 Oki et al. Apr 2013 A1
20130105071 Digiore et al. May 2013 A1
20130116744 Blum et al. May 2013 A1
20130197424 Bedenbaugh Aug 2013 A1
20130197602 Pianca et al. Aug 2013 A1
20130261684 Howard Oct 2013 A1
20130281819 Schmid Oct 2013 A1
20130304152 Bradley et al. Nov 2013 A1
20130317572 Zhu et al. Nov 2013 A1
20130317573 Zhu et al. Nov 2013 A1
20130317587 Barker Nov 2013 A1
20130325091 Pianca et al. Dec 2013 A1
20140039587 Romero Feb 2014 A1
20140067015 Kothandaraman et al. Mar 2014 A1
20140067023 Register et al. Mar 2014 A1
20140074182 Wolf, II Mar 2014 A1
20140114150 Pogue et al. Apr 2014 A1
20140122379 Moffitt et al. May 2014 A1
20140142664 Roukes et al. May 2014 A1
20140163639 Zhu Jun 2014 A1
20140200639 De La Rama Jul 2014 A1
20140296953 Pianca et al. Oct 2014 A1
20140330341 Wolf, II Nov 2014 A1
20140343647 Romero et al. Nov 2014 A1
20140353001 Romero et al. Dec 2014 A1
20140358207 Romero Dec 2014 A1
20140358208 Howard et al. Dec 2014 A1
20140358209 Romero et al. Dec 2014 A1
20140358210 Howard et al. Dec 2014 A1
20150005860 Howard et al. Jan 2015 A1
20150018915 Leven Jan 2015 A1
20150021817 Romero et al. Jan 2015 A1
20150045862 Goldman Feb 2015 A1
20150045864 Howard Feb 2015 A1
20150051681 Hershey Feb 2015 A1
20150066111 Blum et al. Mar 2015 A1
20150066120 Govea Mar 2015 A1
20150151113 Govea et al. Jun 2015 A1
20150202456 Andersen Jul 2015 A1
20150290461 Min et al. Oct 2015 A1
20150306414 Nielsen et al. Oct 2015 A1
20150360031 Bornzin et al. Dec 2015 A1
20150375006 Denison et al. Dec 2015 A1
20160030749 Carcieri et al. Feb 2016 A1
20160045740 Rezai et al. Feb 2016 A1
20160082251 Moffitt et al. Mar 2016 A1
20160082253 Moffitt et al. Mar 2016 A1
20160228692 Steinke et al. Aug 2016 A1
20160250474 Stack et al. Sep 2016 A1
20160256689 Vallejo et al. Sep 2016 A1
20160271392 Vallejo et al. Sep 2016 A1
20160271413 Vallejo et al. Sep 2016 A1
20160287885 Saini Oct 2016 A1
20160296745 Govea et al. Oct 2016 A1
20160346557 Bokil Dec 2016 A1
20160361543 Kaula et al. Dec 2016 A1
20160375258 Steinke Dec 2016 A1
20170061627 Bokil Mar 2017 A1
20170095670 Ghaffar et al. Apr 2017 A1
20170100580 Olson Apr 2017 A1
20170136254 Simon et al. May 2017 A1
20170259078 Howard Sep 2017 A1
20170281966 Basiony Oct 2017 A1
20170304633 Zhang Oct 2017 A1
20170348522 Stoffregen et al. Dec 2017 A1
20170361108 Leven Dec 2017 A1
20170361122 Chabrol et al. Dec 2017 A1
20180028820 Nageri Feb 2018 A1
20180064930 Zhang et al. Mar 2018 A1
20180078776 Mustakos et al. Mar 2018 A1
20180104482 Bokil Apr 2018 A1
20180110971 Serrano Carmona Apr 2018 A1
20180154152 Chabrol et al. Jun 2018 A1
20180193655 Zhang et al. Jul 2018 A1
20180229042 Kaula et al. Aug 2018 A1
20180243570 Malinowski et al. Aug 2018 A1
20180256906 Pivonka et al. Sep 2018 A1
20180318578 Ng et al. Nov 2018 A1
20180326219 Wolf, II Nov 2018 A1
20180369606 Zhang et al. Dec 2018 A1
20180369607 Zhang et al. Dec 2018 A1
20180369608 Chabrol Dec 2018 A1
20190209834 Zhang et al. Jul 2019 A1
20190209849 Hershey et al. Jul 2019 A1
20200094047 Govea et al. Mar 2020 A1
20200155854 Leven et al. May 2020 A1
20200271796 Tahon et al. Aug 2020 A1
20200376262 Clark et al. Dec 2020 A1
20210008389 Featherstone et al. Jan 2021 A1
20210016111 Vansickle et al. Jan 2021 A1
Foreign Referenced Citations (12)
Number Date Country
02091935 Nov 2002 WO
2008118042 Oct 2008 WO
2011031131 Mar 2011 WO
2011150430 Dec 2011 WO
2012103543 Aug 2012 WO
2014081449 May 2014 WO
2014143387 Sep 2014 WO
2015164571 Oct 2015 WO
2019183054 Sep 2019 WO
2019183068 Sep 2019 WO
2019183075 Sep 2019 WO
2019183078 Sep 2019 WO
Non-Patent Literature Citations (22)
Entry
Baxter, G.D. et al., Effects of Low Intensity Infrared Laser Irradiation Upon Conduction in the Human Median Nerve In Vivo, Experimental Physiology (1994) 79, 227-234.
Chow, Roberta et al., Roberta et al., Inhibitory Effects of Laser Irradiation on Peripheral Mammalian Nerves and Relevance to Analgesic Effects: A Systematic Review, Photomedicine and Laser Surgery (2011) 29:6, 365-381.
Kono, Toru et al., Cord Dorsum Potentials Suppressed by Low Power Laser Irradiation on a Peripheral Nerve in the Cat, Journal of Clinical Laser Medicine & Surgery (1993) 11:3, 115-118.
Snyder-Mackler, Lynn et al., Effect of Helium-Neon Laser Irradiation on Peripheral Sensory Nerve Latency, Phys. Ther. (1988), 68:223-225.
U.S. Appl. No. 12/177,823, Entitled: Lead With Transition and Methods of Manufacture and Use, Inventor: Pianca et al., filed Jul. 22, 2008, 22 pages.
U.S. Appl. No. 13/750,725, Entitled: Systems and Methods for Identifying the Circumferential Positioning of Electrodes of Leads for Electrical Stimulation Systems, Inventor: Pianca et al., filed Jan. 25, 2013, 36 pages.
U.S. Appl. No. 62/292,083, Entitled: Implantable Optical Stimulation Lead and Methods of Making and Using, Inventor: Orinski, filed Feb. 5, 2016, 29 pages.
U.S. Appl. No. 62/424,130, Entitled: Implantable Optical Stimulation Lead and Methods of Making and Using, Inventor: Orinski, filed Nov. 18, 2016, 34 pages.
U.S. Appl. No. 13/902,749, Entitled: Low-Level Laser Therapy, Inventor: Zhu et al., filed May 24, 2013, 66 pages.
U.S. Appl. No. 13/902,754, Entitled: Combination Electrical Stimulation and Low-Level Laser Therapy, Inventor: Zhu et al., filed May 24, 2013, 70 pages.
U.S. Appl. No. 15/450,969, Entitled: Implantable Optical Stimulation Leads and Methods of Making and Using, Inventor: Joshua Dale Howard, filed Mar. 6, 2017, 29 pages.
U.S. Appl. No. 62/411,203, Entitled: Electrical Stimulation Methods With Optical Observation and Devices Therefor, Inventor: Raul Enrique Serrano Carmona, filed Oct. 21, 2016, 41 pages.
Darlot, Fannie et al., Near-infrared light is neuroprotective in a monkey model of Parkinson's disease (2006), 30 pages.
International Search Report and Written Opinion from International Patent Application No. PCT/US2017/015846, dated May 3, 2017.
Micah S Siegel, Ehud Y Isacoff, A Genetically Encoded Optical Probe of Membrane Voltage, Neuron, vol. 19, Issue 4, Oct. 1997, pp. 735-741, ISSN 0896-6273, http://dx.doi.org/10.1016/S0896-6273(00)80955-1.
Barnett L, Platisa J, Popovic M, Pieribone VA, Hughes T. A Fluorescent, Genetically-Encoded Voltage Probe Capable of Resolving Action Potentials. (2012) (http://www.sciencedirect.com/science/article/pii/S0896627300809551).
Brennan KC, Toga AW. Intraoperative Optical Imaging. In: Frostig RD, editor. In Vivo Optical Imaging of Brain Function. 2nd edition. Boca Raton (FL): CRC Press/Taylor & Francis; 2009. Chapter 13. Available from: http://www.ncbi.nlm.nih.gov/books/NBK20224/.
Use of NAD(P)H and flavoprotein autofluorescence transients to probe neuron and astrocyte responses to synaptic activation. Shuttleworth 2010 Neurochemestry international.
Official Communication for U.S. Appl. No. 15/421,001 dated Oct. 18, 2018.
Official Communication for U.S. Appl. No. 15/421,001 dated Jan. 10, 2019.
Vallejo, Ricardo, Kerry Bradley, and Leonardo Kapural. “Spinal cord stimulation in chronic pain: Mode of action.” Spine 42 (2017): S53-S60.
Vivianne L. Tawfik, Su-Youne Chang, Frederick L. Hitti, David W. Roberts, James C. Leiter, Svetlana Jovanovic, Kendall H. Lee, Deep Brain Stimulation Results in Local Glutamate and Adenosine Release: Investigation Into the Role of Astrocytes, Neurosurgery, vol. 67, Issue 2, Aug. 2010, pp. 367-375, https://doi.org/10.1227/01.NEU.0000371988.73620.4C.
Related Publications (1)
Number Date Country
20190262625 A1 Aug 2019 US
Provisional Applications (2)
Number Date Country
62424130 Nov 2016 US
62292083 Feb 2016 US
Continuations (1)
Number Date Country
Parent 15421001 Jan 2017 US
Child 16412157 US